Disease progression strikingly differs in research and real-world Parkinson’s populations

Data Availability

Authors had primary access to all data sources used in this study (BKB). All data used in this study are secondary use and therefore the authors must direct those interested in using any data involved to their source:

1. Harvard Biomarkers set is accessible through Accelerating Medicines Partnership program for Parkinson’s disease https://amp-pd.org/unified-cohorts/hbs and through https://www.bwhparkinsoncenter.org/biobank/

2. Mass General Brigham EMR; https://rc.partners.org/about/who-we-are-risc/research-patient-data-registry

3. Optum® Integrated Claims-EHR Data⁴⁴ (https://www.optum.com/content/dam/optum3/optum/en/resources/fact-sheets/Integrated-Data-product-sheet.pdf),

4. Fox Insight⁴³ https://foxinsight.michaeljfox.org/